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1.19%, 95% CI: 1.04–1.34, P= 0.007) and composite morbidity(odds
ratio 1.36%, 95% CI: 1.05–1.77, P= 0.02) after AVR. Mortality and
composite morbidity were sign ﬁcantly higher with lower levels of pre-
operative Hb.
Conclusions: Preoperative anaemia is a common ﬁnding in patients
undergoing aortic valve surgery and is an important and potentially
modiﬁable risk factor for postoperative morbidity and mortality.
http://dx.doi.org/10.1016/j.ehj.2013.12.054
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bypass grafting during the early postoperative period
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Departments, Egypt.
Atrial ﬁbrillation (AF), show to be a common postoperative com-
plication, observed after coronary artery bypass grafting (CABG) Dur-
ing the ﬁrst 7 postoperative days in 7–40% of patients. Some studies
conclude that oﬀ-pump coronary artery bypass (OPCABG) may
decrease the incidence of AF, whereas the combination of CABG with
heart valve replacement may result in more frequent postoperative
atrial ﬁbrillation. The aim of our study was to compare the early post-
operative AF incidence rate during ICU stay in three groups of
patients: after CABG, OPCABG, and CABG combined with valve
replacement.
Material and methods: During the period from January 2009 till Janu-
ary 2012. Clinical proﬁle of 650 patients were included in a prospective
study , factors having potential inﬂuence on postoperative AF did not
show any signiﬁcant diﬀerences between the groups. The presence of
arrhythmia history was the reason of excluding 42 patients from the
statistical analysis. 525 cases after conventional CABG, 96 after
OPCABG, and 29 after CABG combined with valve surgery were
analyzed.
Results: Atrial ﬁbrillation occurred during the postoperative ICU stay
in 9.8% of patients after CABG, in 10.2% after OPCABG, and in 21%
after CABG combined with valve replacement. There was no signiﬁ-
cant diﬀerence between CABG and OPCABG groups (P ¼ 0:965).
We observed a statistically signiﬁcant increase of the early postopera-
tive atrial ﬁbrillation incidence rate in patients after CABG combined
with valve replacement, when compared with both CABG+ OP-
CABG groups (P ¼ 0:005).
Conclusions: (1) Atrial ﬁbrillation is a common postoperative compli-
cation after myocardial revascularization procedures which prolong
ICU stay. (2) The study did not show that the incidence of postoper-
ative AF is inﬂuenced by the technique of coronary artery bypass
grafting: with or without CPB. (3) The prevalence of postoperative
AF increase when CABG is combined with valve replacement.
http://dx.doi.org/10.1016/j.ehj.2013.12.055
Regression of severe tricuspid regurgitation after mitral balloon valvot-
omy for severe mitral stenosis
Mohamed Eid Fawzy.
Background: Signiﬁcant tricuspid regurgitation (TR) is occasionally
associated with severe mitral stenosis and has an adverse impact on
morbidity and mortality in patients undergoing mitral valve surgery.
However, the eﬀect of successful mitral balloon valvotomy (MBV)
on signiﬁcant TR is not fully elucidated. The aim of this study was
to investigate TR after MBV in patients with severe mitral stenosis.
Methods: We analyzed the data of 53 patients with signiﬁcant TR
(gradeP2, on a 1 to 3 scale) from the mitral balloon valvotomy data-
base at our hospital. Patients were evaluated by Doppler echocardiog-
raphy before valvotomy and at follow-up 1 to 13 years after MBV.
Patients were divided into group A (27 patients), in whom TR
regressed by P1 scale, and group B (26 patients), in whom TR did
not regress.
Results: The Doppler-determined pulmonary artery systolic pressure
was initially higher and decreased at follow-up more in group A (from
70.7 ± 23.8 to 36.5 ± 8.3 mmHg; P < :0001) than in group B (from
48.7 ± 17.8 to 41.6 ± 13.1 mmHg; P=NS). Compared with patients
in group B, patients in group A were younger (25 ± 10 vs
35 ± 11 years; P < :005), had higher prevalence of functional TR
(85% vs 8%; P < :0001), and had lower incidence of atrial ﬁbrillation
(7% vs 38%; P < :005). Signiﬁcant decrease in right ventricular end-
diastolic dimension after MBV was noted in group A but not in group
B. The mitral valve area at late follow-up was larger in group A than in
group B (1.8 ± 0.3 vs 1.6 ± 0.3 cm2; P< .05).
Conclusions: Regression of signiﬁcant TR after successful MBV in
patients with severe mitral stenosis was observed in patients who had
severe pulmonary hypertension. This improvement in TR occurred
even in the presence of organic tricuspid valve disease.
http://dx.doi.org/10.1016/j.ehj.2013.12.056
Reperfusion therapy in renal dysfunction patients presenting with
STEMI: Which is better in the Tunisian context?
N. Bouchahda, M. Hassine, G. Chniti, M. Mahjoub, Z. Dridi, F.
Betbout, H. Gamra.
Background: Patients with renal insuﬃciency experience worse prog-
nosis after STEMI. Current guidelines do not clearly draw speciﬁc
strategies for renal dysfunction (RD) patients, and most clinical trials
exclude them from the study population.
Aim of the study: To compare primary PCI (PPCI) and thrombolysis
(using Strepokinase) results as well as in-hospital mortality after suc-
cessful reperfusion between patients with or without RD.
Methods: From January 1995 to October 2011, 1388 patients admitted
for STEMI were enrolled in the MIRAMI (MonastIR’s Acute Myo-
cardial Infarction) registry. Two reperfusion groups were identiﬁed:
PPCI (315 patients) and thrombolysis (379 patients). Patients who
underwent rescue PCI were excluded. Due to lacking clearance data,
we used a serum creatinine level >130 lmol/l to deﬁne RD patients.
We compared in each reperfusion group: (1) The success of revascular-
ization (TIMI III ﬂow restoring with <20% residual stenosis after
PPCI, pain relief with ST regression >50% 60 min after thrombolysis)
and (2) the in-hospital mortality rate after reperfusion success between
the RD patients (RD+) and normal renal function patients (RD).
Results: Ninety patients (13%) had RD, 50% of which underwent
PPCI, and 50% received thrombolytics. Among RD+ and RD-
groups, baseline characteristics were similar between the two reperfu-
sion groups.
In the PPCI group, although TIMI ﬂow was similar before angio-
plasty (p ¼ 0:82), TIMI III restoring was signiﬁcantly lower in the
RD+ group (78.6% vs 91.8%, p ¼ 0:013). Suboptimal result was also
higher in the RD+ group (13.6% vs 2.7%, p < 0:001), but ST regres-
sion after TIMI III achievement was similar in the 2 groups (p ¼ 0:43)
reﬂecting probably no microvascular damage.
In the thrombolysis group, successful reperfusion was also signiﬁ-
cantly lower when RD exists (58% vs 74%, p ¼ 0:03).
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